Wüllner, Ullrich

Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients

Bedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., & Wüllner, U. (2017) · Genome Medicine

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 642

Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans

Striepens, N., Kendrick, K. M., Hanking, V., Landgraf, R., Wüllner, U., Maier, W., & Hurlemann, R. (2013) · Scientific Reports

Neuroendocrine regulation and behaviorOlfactory and Sensory Function Studies

Cited by 452

Systematic Analysis of Gut Microbiome Reveals the Role of Bacterial Folate and Homocysteine Metabolism in Parkinson’s Disease

Rosario, D., Bidkhori, G., Lee, S., Bedarf, J., Hildebrand, F., Le Chatelier, E., Uhlen, M., Ehrlich, S. D., Proctor, G., Wüllner, U., et al. (2021) · Cell Reports

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 167

Bright light therapy in Parkinson's disease: a pilot study

Paus, S., Schmitz‐Hübsch, T., Wüllner, U., Vogel, A., Klockgether, T., & Abele, M. (2007) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsCircadian rhythm and melatonin

Cited by 162

Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase

Heneka, M. T., L. Feinstein, D., Galea, E., Gleichmann, M., Wüllner, U., & Klockgether, T. (1999) · Journal of Neuroimmunology

Peroxisome Proliferator-Activated ReceptorsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 150

Advanced glycation end products and protein carbonyl levels in plasma reveal sex-specific differences in Parkinson's and Alzheimer's disease

Sharma, A., Weber, D., Raupbach, J., Dakal, T. C., Fließbach, K., Ramirez, A., Grune, T., & Wüllner, U. (2020) · Redox Biology

Advanced Glycation End Products researchAlzheimer's disease research and treatments

Cited by 120

DNA methylation in Parkinson's disease

Wüllner, U., Kaut, O., deBoni, L., Piston, D., & Schmitt, I. (2016) · Journal of Neurochemistry

Parkinson's Disease Mechanisms and TreatmentsEpigenetics and DNA Methylation

Cited by 107

Aberrant NMDA receptor DNA methylation detected by epigenome-wide analysis of hippocampus and prefrontal cortex in major depression

Kaut, O., Schmitt, I., Hofmann, A., Hoffmann, P., Schlaepfer, T. E., Wüllner, U., & Hurlemann, R. (2015) · European Archives of Psychiatry and Clinical Neuroscience

Epigenetics and DNA MethylationTreatment of Major Depression

Cited by 68

DNA methylation alterations in iPSC- and hESC-derived neurons: Potential implications for neurological disease modeling

de Boni, L., Gasparoni, G., Haubenreich, C., Tierling, S., Schmitt, I., Peitz, M., Koch, P., Walter, J., Wüllner, U., & Brüstle, O. (2018) · Clinical Epigenetics

Pluripotent Stem Cells ResearchEpigenetics and DNA Methylation

Cited by 47

Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study

Brosseron, F., Kolbe, C., Santarelli, F., Carvalho, S., Antonell, A., Castro‐Gomez, S., Tacik, P., Namasivayam, A. A., Mangone, G., Schneider, R., et al. (2020) · Alzheimer's & Dementia

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 47

Transcutaneous vagal nerve stimulation improves gastroenteric complaints in Parkinson's disease patients

Kaut, O., Janocha, L., Weismüller, T. J., & Wüllner, U. (2019) · NeuroRehabilitation

Vagus Nerve Stimulation ResearchGastrointestinal motility and disorders

Cited by 36